Plasma melatonin is reduced in Huntington's disease.
Identifieur interne : 004098 ( Ncbi/Merge ); précédent : 004097; suivant : 004099Plasma melatonin is reduced in Huntington's disease.
Auteurs : Eirini Kalliolia [Royaume-Uni] ; Edina Silajdži ; Rajasree Nambron ; Nathan R. Hill ; Anisha Doshi ; Chris Frost ; Hilary Watt ; Peter Hindmarsh ; Maria Björkqvist ; Thomas T. WarnerSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : Melatonin.
- blood : Huntington Disease.
- Adult, Aged, Female, Fourier Analysis, Humans, Male, Middle Aged, Severity of Illness Index.
Abstract
This study was undertaken to determine whether the production of melatonin, a hormone regulating sleep in relation to the light/dark cycle, is altered in Huntington's disease. We analyzed the circadian rhythm of melatonin in a 24-hour study of cohorts of control, premanifest, and stage II/III Huntington's disease subjects. The mean and acrophase melatonin concentrations were significantly reduced in stage II/III Huntington's disease subjects compared with controls. We also observed a nonsignificant trend toward reduced mean and acrophase melatonin in premanifest Huntington's disease subjects. Onset of melatonin rise was significantly more temporally spread in both premanifest and stage II/III Huntington's disease subjects compared with controls. A nonsignificant trend also was seen for reduced pulsatile secretion of melatonin. Melatonin concentrations are reduced in Huntington's disease. Altered melatonin patterns may provide an explanation for disrupted sleep and circadian behavior in Huntington's disease, and represent a biomarker for disease state. Melatonin therapy may help the sleep disorders seen in Huntington's disease.
DOI: 10.1002/mds.26003
PubMed: 25164424
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000405
- to stream PubMed, to step Curation: 000405
- to stream PubMed, to step Checkpoint: 000478
Links to Exploration step
pubmed:25164424Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Plasma melatonin is reduced in Huntington's disease.</title>
<author><name sortKey="Kalliolia, Eirini" sort="Kalliolia, Eirini" uniqKey="Kalliolia E" first="Eirini" last="Kalliolia">Eirini Kalliolia</name>
<affiliation wicri:level="3"><nlm:affiliation>Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences, UCL Institute of Neurology, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences, UCL Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Silajdzi, Edina" sort="Silajdzi, Edina" uniqKey="Silajdzi E" first="Edina" last="Silajdži">Edina Silajdži</name>
</author>
<author><name sortKey="Nambron, Rajasree" sort="Nambron, Rajasree" uniqKey="Nambron R" first="Rajasree" last="Nambron">Rajasree Nambron</name>
</author>
<author><name sortKey="Hill, Nathan R" sort="Hill, Nathan R" uniqKey="Hill N" first="Nathan R" last="Hill">Nathan R. Hill</name>
</author>
<author><name sortKey="Doshi, Anisha" sort="Doshi, Anisha" uniqKey="Doshi A" first="Anisha" last="Doshi">Anisha Doshi</name>
</author>
<author><name sortKey="Frost, Chris" sort="Frost, Chris" uniqKey="Frost C" first="Chris" last="Frost">Chris Frost</name>
</author>
<author><name sortKey="Watt, Hilary" sort="Watt, Hilary" uniqKey="Watt H" first="Hilary" last="Watt">Hilary Watt</name>
</author>
<author><name sortKey="Hindmarsh, Peter" sort="Hindmarsh, Peter" uniqKey="Hindmarsh P" first="Peter" last="Hindmarsh">Peter Hindmarsh</name>
</author>
<author><name sortKey="Bjorkqvist, Maria" sort="Bjorkqvist, Maria" uniqKey="Bjorkqvist M" first="Maria" last="Björkqvist">Maria Björkqvist</name>
</author>
<author><name sortKey="Warner, Thomas T" sort="Warner, Thomas T" uniqKey="Warner T" first="Thomas T" last="Warner">Thomas T. Warner</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25164424</idno>
<idno type="pmid">25164424</idno>
<idno type="doi">10.1002/mds.26003</idno>
<idno type="wicri:Area/PubMed/Corpus">000405</idno>
<idno type="wicri:Area/PubMed/Curation">000405</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000478</idno>
<idno type="wicri:Area/Ncbi/Merge">004098</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Plasma melatonin is reduced in Huntington's disease.</title>
<author><name sortKey="Kalliolia, Eirini" sort="Kalliolia, Eirini" uniqKey="Kalliolia E" first="Eirini" last="Kalliolia">Eirini Kalliolia</name>
<affiliation wicri:level="3"><nlm:affiliation>Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences, UCL Institute of Neurology, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences, UCL Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Silajdzi, Edina" sort="Silajdzi, Edina" uniqKey="Silajdzi E" first="Edina" last="Silajdži">Edina Silajdži</name>
</author>
<author><name sortKey="Nambron, Rajasree" sort="Nambron, Rajasree" uniqKey="Nambron R" first="Rajasree" last="Nambron">Rajasree Nambron</name>
</author>
<author><name sortKey="Hill, Nathan R" sort="Hill, Nathan R" uniqKey="Hill N" first="Nathan R" last="Hill">Nathan R. Hill</name>
</author>
<author><name sortKey="Doshi, Anisha" sort="Doshi, Anisha" uniqKey="Doshi A" first="Anisha" last="Doshi">Anisha Doshi</name>
</author>
<author><name sortKey="Frost, Chris" sort="Frost, Chris" uniqKey="Frost C" first="Chris" last="Frost">Chris Frost</name>
</author>
<author><name sortKey="Watt, Hilary" sort="Watt, Hilary" uniqKey="Watt H" first="Hilary" last="Watt">Hilary Watt</name>
</author>
<author><name sortKey="Hindmarsh, Peter" sort="Hindmarsh, Peter" uniqKey="Hindmarsh P" first="Peter" last="Hindmarsh">Peter Hindmarsh</name>
</author>
<author><name sortKey="Bjorkqvist, Maria" sort="Bjorkqvist, Maria" uniqKey="Bjorkqvist M" first="Maria" last="Björkqvist">Maria Björkqvist</name>
</author>
<author><name sortKey="Warner, Thomas T" sort="Warner, Thomas T" uniqKey="Warner T" first="Thomas T" last="Warner">Thomas T. Warner</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Fourier Analysis</term>
<term>Humans</term>
<term>Huntington Disease (blood)</term>
<term>Male</term>
<term>Melatonin (blood)</term>
<term>Middle Aged</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Melatonin</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Huntington Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Fourier Analysis</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This study was undertaken to determine whether the production of melatonin, a hormone regulating sleep in relation to the light/dark cycle, is altered in Huntington's disease. We analyzed the circadian rhythm of melatonin in a 24-hour study of cohorts of control, premanifest, and stage II/III Huntington's disease subjects. The mean and acrophase melatonin concentrations were significantly reduced in stage II/III Huntington's disease subjects compared with controls. We also observed a nonsignificant trend toward reduced mean and acrophase melatonin in premanifest Huntington's disease subjects. Onset of melatonin rise was significantly more temporally spread in both premanifest and stage II/III Huntington's disease subjects compared with controls. A nonsignificant trend also was seen for reduced pulsatile secretion of melatonin. Melatonin concentrations are reduced in Huntington's disease. Altered melatonin patterns may provide an explanation for disrupted sleep and circadian behavior in Huntington's disease, and represent a biomarker for disease state. Melatonin therapy may help the sleep disorders seen in Huntington's disease.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">25164424</PMID>
<DateCreated><Year>2014</Year>
<Month>10</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>06</Month>
<Day>03</Day>
</DateCompleted>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>29</Volume>
<Issue>12</Issue>
<PubDate><Year>2014</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Plasma melatonin is reduced in Huntington's disease.</ArticleTitle>
<Pagination><MedlinePgn>1511-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.26003</ELocationID>
<Abstract><AbstractText>This study was undertaken to determine whether the production of melatonin, a hormone regulating sleep in relation to the light/dark cycle, is altered in Huntington's disease. We analyzed the circadian rhythm of melatonin in a 24-hour study of cohorts of control, premanifest, and stage II/III Huntington's disease subjects. The mean and acrophase melatonin concentrations were significantly reduced in stage II/III Huntington's disease subjects compared with controls. We also observed a nonsignificant trend toward reduced mean and acrophase melatonin in premanifest Huntington's disease subjects. Onset of melatonin rise was significantly more temporally spread in both premanifest and stage II/III Huntington's disease subjects compared with controls. A nonsignificant trend also was seen for reduced pulsatile secretion of melatonin. Melatonin concentrations are reduced in Huntington's disease. Altered melatonin patterns may provide an explanation for disrupted sleep and circadian behavior in Huntington's disease, and represent a biomarker for disease state. Melatonin therapy may help the sleep disorders seen in Huntington's disease.</AbstractText>
<CopyrightInformation>© © 2014 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalliolia</LastName>
<ForeName>Eirini</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences, UCL Institute of Neurology, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Silajdžić</LastName>
<ForeName>Edina</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nambron</LastName>
<ForeName>Rajasree</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hill</LastName>
<ForeName>Nathan R</ForeName>
<Initials>NR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Doshi</LastName>
<ForeName>Anisha</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Frost</LastName>
<ForeName>Chris</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Watt</LastName>
<ForeName>Hilary</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hindmarsh</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Björkqvist</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Warner</LastName>
<ForeName>Thomas T</ForeName>
<Initials>TT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>08</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>JL5DK93RCL</RegistryNumber>
<NameOfSubstance UI="D008550">Melatonin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005583">Fourier Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006816">Huntington Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008550">Melatonin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Huntington's disease</Keyword>
<Keyword MajorTopicYN="N">circadian rhythm</Keyword>
<Keyword MajorTopicYN="N">melatonin</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>12</Month>
<Day>2</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>7</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>7</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2014</Year>
<Month>8</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>8</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>8</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25164424</ArticleId>
<ArticleId IdType="doi">10.1002/mds.26003</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Bjorkqvist, Maria" sort="Bjorkqvist, Maria" uniqKey="Bjorkqvist M" first="Maria" last="Björkqvist">Maria Björkqvist</name>
<name sortKey="Doshi, Anisha" sort="Doshi, Anisha" uniqKey="Doshi A" first="Anisha" last="Doshi">Anisha Doshi</name>
<name sortKey="Frost, Chris" sort="Frost, Chris" uniqKey="Frost C" first="Chris" last="Frost">Chris Frost</name>
<name sortKey="Hill, Nathan R" sort="Hill, Nathan R" uniqKey="Hill N" first="Nathan R" last="Hill">Nathan R. Hill</name>
<name sortKey="Hindmarsh, Peter" sort="Hindmarsh, Peter" uniqKey="Hindmarsh P" first="Peter" last="Hindmarsh">Peter Hindmarsh</name>
<name sortKey="Nambron, Rajasree" sort="Nambron, Rajasree" uniqKey="Nambron R" first="Rajasree" last="Nambron">Rajasree Nambron</name>
<name sortKey="Silajdzi, Edina" sort="Silajdzi, Edina" uniqKey="Silajdzi E" first="Edina" last="Silajdži">Edina Silajdži</name>
<name sortKey="Warner, Thomas T" sort="Warner, Thomas T" uniqKey="Warner T" first="Thomas T" last="Warner">Thomas T. Warner</name>
<name sortKey="Watt, Hilary" sort="Watt, Hilary" uniqKey="Watt H" first="Hilary" last="Watt">Hilary Watt</name>
</noCountry>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Kalliolia, Eirini" sort="Kalliolia, Eirini" uniqKey="Kalliolia E" first="Eirini" last="Kalliolia">Eirini Kalliolia</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004098 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004098 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:25164424 |texte= Plasma melatonin is reduced in Huntington's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:25164424" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |